Key figures

The Group, continuing operations2) 201720162015201420132012
EBITDA, SEK k-342,580–278,91995,6621,221,92576,389–165,254
EBIT, SEK k-362,835–312,38055,4281,188,73125,164–201,331
Operating margin, %-990.3–335.711.767.35.6–118.0
Profit margin, %-981.8–329.79.767.56.2–123.5
Debt/equity ratio, multiple0.20.10.10.10.10.1
Return on:
shareholders’ equity, %-32.1–18.51.884.13.2–21.4
capital employed, %-32.0–19.32.780.63.3–17.6
total capital, %-28,3–17.32.575.23.3–16.6
Equity/assets ratio, %83.490.289.790.885.781.3
Average number of shares, ‘00021,96326,94129,04831,26031,26031,257
Number of shares at year-end, ‘00020,31926,96626,96631,26031,26031,260
Earnings per share, SEK
Basic earnings per share, continuing operations-16,40–10.941.0936.240.51–7.49
Diluted earnings per share, continuing operations-16,40–10.941.0835.900.51–7.49
Basic earnings per share, discontinued operations-21.441.49–1.19
Diluted earnings per share, discontinued operations-21.391.48–1.19
Basic earnings per share, all operations-16.4010.502.5936.24–0.68–7.49
Diluted earnings per share, all operations-16.4010.472.5635.90–0.68–7.49
Equity per share, before and after dilution, SEK1)25.3164.3854.0463.4227.2727.99
Net worth per share, before and after dilution, SEK1)25.3164.3854.0463.4227.2727.99
Cash flow per share from operating activities, SEK-16.32–6.6811.9532.451.38–4.47
Cash flow per share after investments, SEK-16.9423.0511.4431.884.93–4.69
Cash flow per share after financing activities, SEK-56.0323.03–10.9931.883.37–7.66
Dividend per share, SEK000000
Number of outstanding share warrants57,83562,842238,254294,486249,110394,400
Capital employed514,0571,733,9221,450,1092,032,778955,470963,537
Research and development costs/operating expenses, %79.478.873.160.865.765.4



1) IAS 33 states that potential ordinary shares do not give rise to any dilution effect when their conversion to ordinary shares entails an improvement in earnings per share, which would be the case in conjunction with a conversion of the outstanding share warrants in Medivir.

2) No recalculation has occurred for 2014 and previous years with regard to the discontinued operations in 2016.

Six-year summary

The Group, continuing operations, SEK201720162015201420132012
Income Statements1)
Net sales36,63993,043474,2741,766,989446,146170,647
Total expenses-399,474–405,423–418,846–578,257–420,983–371,978
Operating profit/loss-362,835–312,38055,4281,188,73125,164–201,331
Net financial items3,1065,655–9,2253,9702,470–9,441
Profit/loss after financial items-359,729–306,72546,2031,192,70127,633–210,772
Tax-49011,870–14,495–59,966–11,619–23,325
Profit/loss after tax-360,218–294,85531,7081,132,73516,014–234,098

-31 Dec 201731 Dec 201631 Dec 201531 Dec 201431 Dec 201331 Dec 2012
Balance Sheets
Intangible fixed assets112,742111,854398,022417,577432,080514,389
Tangible fixed assets14,43621,95626,28326,87527,95836,070
Financial fixed assets2,50010,001
Deferred tax receivables-1,00243,18749,238
Inventories and current receivables21,21388,209114,008341,31780,025179,771
Cash and cash equivalents467,7801,698,4811,077,9421,395,621402,220296,727
Equity514,0571,732,9121,450,1091,982,604852,587874,880
Deferred tax liability/provisions-351468
Long-term interest-bearing liabilities-40,00040,000
Long-term non-interest-bearing liabilities-448
Current liabilities102,113188,591165,795201,286102,883160,867
Balance Sheet total616,1711,921,5031,616,2552,183,891995,4701,076,195

1) No recalculation has occurred for 2014 and previous years with regard to the discontinued operations in 2016.